The medical device industry and its largest lobby group have pushed relentlessly to repeal the 2.3 percent medical device tax, and while they didn’t win that battle, they earned a reprieve in the manner of a two-year pause.
At a conference in Philadelphia hosted by MedCity News, Scott Whitaker, president and CEO of AdvaMed, shared some details about how the pause has been a boon to its constituents.
